GlassScriptPhysician profile
William A Faunce
NPI 1285963009
$8,647.04
in general payments reported to CMS, 2019-2025
46 companies · $1,356 in 2025
The $1,356 reported for 2025 was more than what 88% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,652 · 2022: $2,334 · 2023: $1,755 · 2024: $1,550 · 2025: $1,356.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,584 · Education: $76.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,584.30 |
| Education | $76.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,270.23 | 2021-2025 | |
| Teva Pharmaceuticals USA, INC. | $629.70 | 2021-2025 | Ajovy, Austedo Xr, Austedo Xr |
| Amgen INC. | $581.83 | 2021-2025 | Uplizna, Aimovig |
| Novartis Pharmaceuticals Corporation | $413.06 | 2021-2025 | |
| Lilly USA, LLC | $376.41 | 2021-2024 | Amyvid, Emgality, Kisunla |
| Pfizer INC. | $371.92 | 2023-2025 | |
| Genzyme Corporation | $371.33 | 2021-2023 | |
| Kyowa Kirin, INC. | $323.79 | 2021-2024 | Nourianz |
| Boston Scientific Corporation | $304.33 | 2022-2025 | Vercise |
| Biohaven Pharmaceutical Holding Company LTD. | $277.04 | 2022 | |
| Lundbeck LLC | $272.58 | 2022-2025 | Vyepti, Rexulti |
| Biogen, INC. | $258.30 | 2021-2025 | Leqembi, Skyclarys |
| Otsuka America Pharmaceutical, INC. | $241.87 | 2023-2024 | Rexulti, Nuedexta |
| Biohaven Pharmaceuticals, INC. | $225.39 | 2021 | |
| Octapharma USA, INC. | $220.44 | 2022-2025 | Panzyga |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Faunce listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.